{"url":"https://lda.senate.gov/api/v1/filings/f31ce4eb-2aaa-4430-8b8a-4bdf32d3e6d0/","filing_uuid":"f31ce4eb-2aaa-4430-8b8a-4bdf32d3e6d0","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2024,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/f31ce4eb-2aaa-4430-8b8a-4bdf32d3e6d0/print/","filing_document_content_type":"text/html","income":null,"expenses":"100000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Allison Giles","dt_posted":"2024-10-17T09:44:03-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"P.O. Box 6924","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"Arlington","registrant_state":"VA","registrant_zip":"22206","registrant":{"id":87654,"url":"https://lda.senate.gov/api/v1/registrants/87654/","house_registrant_id":36626,"name":"THE COOK GROUP INC.","description":"Medical device manufacturer.","address_1":"P.O. Box 6924","address_2":null,"address_3":null,"address_4":null,"city":"Arlington","state":"VA","state_display":"Virginia","zip":"22206","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALLISON GILES","contact_telephone":"+1 202-631-5577","dt_updated":"2026-07-21T16:23:20.759644-04:00"},"client":{"id":173616,"url":"https://lda.senate.gov/api/v1/clients/173616/","client_id":12,"name":"THE COOK GROUP INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"VA","state_display":"Virginia","country":"US","country_display":"United States of America","ppb_state":"VA","ppb_state_display":"Virginia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-05-04"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Medicare Reimbursement: Medicare coverage of breakthrough technologies (H.R. 1691); Transitional Coverage for Emerging Technologies (TCET); CMS NPRM TCET UDI inclusion in Medicare claims form Nursing Workforce Shortage Women's Health Research and Innovation Initiative (Executive Order) FDA Reform: cellular therapy RMAT designation; medical device shortage reporting; domestic production of medical products; use of real world data (RWD) and real world evidence (RWE); (H.R. 3723) Medical Device Electronic Labeling Act; FDA modernization Data Privacy legislation: H.R. 8818, the \"American Privacy Rights Act of 2024\" provisions covering biomedical research and HIPAA","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Research & development tax amortization (S.866/H.R.2673); Neighborhood Homes Investment Tax Credit bill (S.657); Affordable Housing Credit Improvement Act (S. 1557/H.R. 3238); Rural Opportunity Zone and Investment Act (H.R. 3906)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CPT","general_issue_code_display":"Copyright/Patent/Trademark","description":"Patent legislation: beneficiary owner","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HOU","general_issue_code_display":"Housing","description":"USDA Sec. 502 low-income, rural areas in need of affordable housing proposals for workforce development","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"CAW","general_issue_code_display":"Clean Air and Water (quality)","description":"EPA regulation of Ethylene Oxide NESHAP Rule and Re-Registration FIFRA PID Rule PFAS issues: Fluoropolymers","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":49266,"prefix":"ms","prefix_display":"MS.","first_name":"ALLISON","nickname":null,"middle_name":"HOBBS","last_name":"GILES","suffix":null,"suffix_display":null},"covered_position":"Vice President of Global Government Affairs","new":false}],"government_entities":[{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}